IPCA LABORATORIES
Back to Income Statement
|
IPCA LABORATORIES Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹8,897 Cr | ₹7,662 Cr | ₹6,204 Cr | ₹5,797 Cr | ₹5,395 Cr |
What is the latest Revenue of IPCA LABORATORIES ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹8,897 Cr |
| Mar2025 | ₹7,662 Cr |
| Mar2024 | ₹6,204 Cr |
| Mar2023 | ₹5,797 Cr |
| Mar2022 | ₹5,395 Cr |
How is Revenue of IPCA LABORATORIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹8,897 Cr | 16.11 | |
| Mar2025 | ₹7,662 Cr | 23.50 | |
| Mar2024 | ₹6,204 Cr | 7.03 | |
| Mar2023 | ₹5,797 Cr | 7.45 | |
| Mar2022 | ₹5,395 Cr | - | |
Compare Revenue of peers of IPCA LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| IPCA LABORATORIES | ₹49,268.5 Cr | -0.4% | 0.2% | 53.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,497.0 Cr | 5.2% | 4.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹294,146.0 Cr | 3.6% | 7.6% | 50.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,474.0 Cr | 3.4% | 0.7% | 32.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,349.0 Cr | 2.3% | 14% | 13.6% | Stock Analytics | |
| CIPLA | ₹113,989.0 Cr | 2% | 6% | -6.7% | Stock Analytics | |
IPCA LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| IPCA LABORATORIES | -0.4% |
0.2% |
53.3% |
| SENSEX | 7% |
11.5% |
-3.5% |
You may also like the below Video Courses